Pet DRx To Begin Trading on Nasdaq Capital Market

  
    
  
  
    
      Pet DRx Corporation (OTCBB:PDXC)(OTCBB:PDXCW)(OTCBB:PDXCU) 
      today announced that its common stock, warrants and units will commence 
      trading on the Nasdaq Capital Market under the symbols “VETS,” 
      “VETSW,” and “VETSU” 
      respectively, when the market opens on May 29, 2008.
    
    
      Pet DRx stock, warrants and units formerly traded on the OTC Bulletin 
      Board under the symbols “PDXC,” 
      “PDXCW,” and “PDXCU,” 
      respectively.
    
    
      “We are excited to have been approved for 
      listing on the Nasdaq Capital Market. The listing on Nasdaq is an 
      important milestone for Pet DRx, and includes a number of benefits, such 
      as increased visibility in the financial community, greater liquidity 
      for our stock and a larger potential investor base,” 
      said Robert Wallace, Chief Executive Officer of PetDRx.
    
    
      About Pet DRx
    
    
      Pet DRx Corporation, headquartered in Brentwood, Tennessee, provides 
      veterinary primary care and specialized services to companion animals 
      through a network of fully-owned veterinary hospitals. The Company 
      currently owns and operates 26 leading veterinary hospitals in the state 
      of California, which it has organized into unique, regional “hub 
      and spoke” networks. Pet DRx provides a full 
      range of general medical treatments for companion animals, including (i) 
      preventive care, such as examinations, vaccinations, spaying/neutering 
      and dental care and (ii) a broad range of specialized diagnostic and 
      medical services, such as internal medicine, surgery, cardiology, 
      ophthalmology, dermatology, oncology, neurology, x-ray, ultrasound and 
      other services.
    
    
      SAFE HARBOR STATEMENT
    
    
      Certain statements and information included in this press release, 
      including statements as to the expected visibility and liquidity of the 
      Company’s common shares, constitute “forward-looking 
      statements” within the meaning of the Federal 
      Private Securities Litigation Reform Act of 1995. These forward-looking 
      statements are subject to risks and uncertainties that may cause actual 
      results to differ materially, including, but not limited to, the 
      ability of the Company to successfully acquire, integrate and operate 
      veterinary hospitals and clinics, requirements or changes affecting the 
      businesses in which the Company is engaged, veterinary services trends, 
      including factors affecting supply and demand, dependence on 
      acquisitions for growth, labor and personnel relations, changing 
      interpretations of generally accepted accounting principles and other 
      risks detailed from time to time in the Company’s 
      SEC reports, including its Current Report on Form 8-K, as amended, filed 
      on April 4, 2008 and its Registration Statement on Form S-4, as 
      amended, filed on November 8, 2007. These forward-looking statements 
      speak only as of the date hereof. The Company disclaims any intention or 
      obligation to update or revise any forward-looking statements.